Evidence of efficacy is not enough to develop recommendations: Antibiotics for treatment of traveler's diarrhea [1]

Clinical Infectious Diseases

Volumn 44, Issue 11, 2007, Pages 1520-

  Genton, Blaise ^a,b,c   D'Acremont, Valérie ^a,b  

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE; LEVOFLOXACIN;

ANTIBIOTIC THERAPY; CLINICAL TRIAL; DATA ANALYSIS; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG USE; ENTEROBACTERIACEAE; EVALUATION; EVIDENCE BASED MEDICINE; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SINGLE DRUG DOSE; TRAVELLER DIARRHEA;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DIARRHEA; DRUG RESISTANCE, BACTERIAL; HUMANS; MILITARY PERSONNEL; OFLOXACIN; THAILAND; TRAVEL;

EID: 34248999158     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517837     Document Type: Letter

References (4)

1. Tribble DR, Sanders JW, Pang LW, et al. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 2007; 44:338-46.
2. Jiang ZD, Lowe B, Verenkar MP, et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 2002; 185:497-502.
3. Von Sonnenburg F, Tornieporth N, Waiyaki P, et al. Risk and aetiology of diarrhoea at various tourist destinations. Lancet 2000; 356:133-4.
4. De Bruyn G, Hahn S, Borwick A. Antibiotic treatment for travellers' diarrhoea. Cochrane Database Syst Rev 2000:CD002242.